Mitchell, James
- Division of Clinical Sciences - Nci (no department on record)
- Division of Basic Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,925
- Rising Star
- Sustained Excellence
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#1,925
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Mitchell, James as a PI. Multi-PI records show the full award amount for context.
- $1.8Maward amount
- 1ZIABC010946-16ZIAContact PIProtection against Radiation-Induced Carcinogenesis$584.3Kaward amount
- 1ZIASC006387-36ZIAContact PINitroxides as Protectors Against Oxidative Stress$584.3Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Mitchell, James as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardDivision of Clinical Sciences - Nci
- 2008$500K Cumulative Funding
- 2008Multi-Institutional ResearchAwards at 2 institutions
- 2009$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #3234
- 2009Entered Top 25% NationallyRanked #3234
- 2011$5M Cumulative Funding
- 2012$10M Cumulative Funding
- 2012Entered Top 10% NationallyRanked #702
- 2012Entered Top 5% NationallyRanked #702
- 2017$25M Cumulative Funding